1985
DOI: 10.1007/bf03010036
|View full text |Cite
|
Sign up to set email alerts
|

Mitral valve prolapse

Abstract: Mitral valve prolapse (MVP) was first described as a clinical-pathological entity in the mid 1960's t'2 when the auscultatory findings of a mid-systolic click were correlated with angiographically demonstrated valve prolapse. Prior to that time, these findings were thought to be caused by extra-cardiac pathology. Since the advent of echo-cardiography, this entity has been increasingly recognized and diagnosed. IncidenceMitral valve prolapse is the most common valvular cardiac abormality with published prevalen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1986
1986
1996
1996

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The dysrhythmias caused by the prolapsed leaflets may be enhanced further by increased catecholamine level, because an increased sensitivity to catecholamines is seen in patients with mitral valve prolapse. 4 Halothane itself is well known to sensitize the heart to catecholamines.…”
Section: Discussionmentioning
confidence: 99%
“…The dysrhythmias caused by the prolapsed leaflets may be enhanced further by increased catecholamine level, because an increased sensitivity to catecholamines is seen in patients with mitral valve prolapse. 4 Halothane itself is well known to sensitize the heart to catecholamines.…”
Section: Discussionmentioning
confidence: 99%